Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes
Autor: | Eduardo Elias Vieira de Carvalho, Fernanda Rodrigues de Souza, Minna Moreira Dias Romano, Erica C. Campos Pulici, Marcus Vinicius Simões, Marcos A. Rossi, Helio Cesar Salgado, Benedito Carlos Maciel, João Lucas O’Connell, Denise M. Tanaka, Rubens Fazan-Junior |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
medicine.medical_specialty medicine.medical_treatment Diastole Cardiomyopathy 030204 cardiovascular system & hematology Toxicology Pathology and Forensic Medicine RATOS 03 medical and health sciences 0302 clinical medicine Internal medicine MODELOS ANIMAIS DE DOENÇAS Animals Medicine Rats Wistar Saline Cardiotoxicity Antibiotics Antineoplastic Ejection fraction Cumulative dose business.industry Heart Dilated cardiomyopathy Cell Biology General Medicine medicine.disease Rats Disease Models Animal Doxorubicin 030220 oncology & carcinogenesis Heart failure Cardiology Cardiomyopathies business |
Zdroj: | Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP |
ISSN: | 0940-2993 |
DOI: | 10.1016/j.etp.2017.01.004 |
Popis: | Objectives Doxorubicin (DXR), an anthracyclic antineoplastic agent, is one of the most commonly drug utilized to induce dilated cardiomyopathy (DCM) and heart failure (HF), but the well optimized protocol for cardiomyopathy induction leading to development of cardiac systolic dysfunction is unclear. This study aims to critically compare short-term and long-term DXR injection protocols for the induction of DCM in rats. Methods Animals were allocated into 3 experimental groups: a ST (short-term DXR injection) group, in which animals received 6 intraperitoneal (i.p.) injections of DXR (2.5 mg/kg per dose) over a period of 2 weeks (cumulative dose of 15 mg/kg); a LT (long-term DXR injection) group in which animals received weekly i.p. injections of DXR (2 mg/kg per dose) over a period of 9 weeks (cumulative dose of 18 mg/kg); and a control group in which animals received an appropriate volume of 0.9% saline i.p. All animals were submitted to echocardiography analysis at baseline and after completion treatment. Afterwards, the hearts were collected for conventional light microscopy and collagen quantification. Results Morphological myocardial analysis of both DXR-treated groups showed an identical pattern of swollen and vacuolated cardiomyocytes and disorganization of myofibrils. There was pronounced interstitial fibrosis in both groups of DXR-treated hearts as compared to controls, as assessed by the interstitial collagen volume fraction. There was no difference in interstitial fibrosis between the ST and LT groups. The echocardiography analysis of the LT group showed structural and functional findings compatible with DCM, including increased left ventricular systolic (5.02 ± 0.96 mm) and diastolic (7.68 ± 0.96 mm) dimensions and reduction of ejection fraction (69.40 ± 8.51%) as compared to the ST group (4.10 ± 0.89 mm, 7.32 ± 0.84, and 79.68 ± 7.23%, respectively) and control group (4.07 ± 0.72 mm, 7.17 ± 0.68 mm and 80.08 ± 4.71%, respectively), ANOVA p Conclusions These results indicate that LT injection of DXR is more effective than ST injection in inducing left ventricular dysfunction and structural cardiac changes resembling those found in dilated cardiomyopathy. |
Databáze: | OpenAIRE |
Externí odkaz: |